2-29228949-G-C

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP3BP6_Moderate

The NM_004304.5(ALK):​c.2750C>G​(p.Thr917Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,125,708 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T917A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000044 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000014 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ALK
NM_004304.5 missense

Scores

5
10
3

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 7.50

Publications

1 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.776
BP6
Variant 2-29228949-G-C is Benign according to our data. Variant chr2-29228949-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 3524408.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.2750C>Gp.Thr917Arg
missense
Exon 16 of 29NP_004295.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.2750C>Gp.Thr917Arg
missense
Exon 16 of 29ENSP00000373700.3Q9UM73
ALK
ENST00000618119.4
TSL:5
c.1619C>Gp.Thr540Arg
missense
Exon 15 of 28ENSP00000482733.1A0A087WZL3

Frequencies

GnomAD3 genomes
AF:
0.0000435
AC:
2
AN:
45952
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0000928
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000455
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000170
AC:
3
AN:
176352
AF XY:
0.0000204
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000309
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000142
AC:
16
AN:
1125708
Hom.:
0
Cov.:
26
AF XY:
0.0000199
AC XY:
11
AN XY:
552584
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000795
AC:
2
AN:
25170
American (AMR)
AF:
0.0000362
AC:
1
AN:
27632
Ashkenazi Jewish (ASJ)
AF:
0.0000502
AC:
1
AN:
19926
East Asian (EAS)
AF:
0.0000963
AC:
3
AN:
31144
South Asian (SAS)
AF:
0.0000634
AC:
3
AN:
47302
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42952
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4698
European-Non Finnish (NFE)
AF:
0.00000568
AC:
5
AN:
880658
Other (OTH)
AF:
0.0000216
AC:
1
AN:
46226
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.259
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000435
AC:
2
AN:
45952
Hom.:
0
Cov.:
0
AF XY:
0.0000437
AC XY:
1
AN XY:
22900
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000928
AC:
1
AN:
10774
American (AMR)
AF:
0.00
AC:
0
AN:
3588
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2580
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2268
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2654
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
94
European-Non Finnish (NFE)
AF:
0.0000455
AC:
1
AN:
21968
Other (OTH)
AF:
0.00
AC:
0
AN:
590
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.053
D
MetaRNN
Pathogenic
0.78
D
MetaSVM
Benign
-0.64
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
7.5
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.32
Sift
Uncertain
0.016
D
Sift4G
Uncertain
0.013
D
Polyphen
0.97
D
Vest4
0.86
MutPred
0.26
Loss of ubiquitination at K912 (P = 0.0283)
MVP
0.73
MPC
0.75
ClinPred
0.92
D
GERP RS
5.4
Varity_R
0.57
gMVP
0.91
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773447647; hg19: chr2-29451815; API